Lidocaine, often known by its brand names such as Xylocaine, is a widely used local anaesthetic and antiarrhythmic agent. It plays a crucial role in both pain management and the treatment of certain heart conditions, making it an essential drug in medical practice.
Lidocaine’s efficacy, along with the risk of toxicity if not administered correctly, highlights the importance of understanding its applications and the need for careful monitoring of its levels in specific clinical settings.
Randox Toxicology have developed a new lidocaine single-plex biochip assay which is available on the Evidence MultiSTAT, to aid in the monitoring of lidocaine at the location of treatment.
Benefits
Product Information
Analyser Process
